ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,596,000 | +22.9% | 76,386 | +4.0% | 0.13% | +35.1% |
| Q2 2020 | $6,995,000 | -10.2% | 73,421 | -15.3% | 0.09% | -22.3% |
| Q1 2020 | $7,789,000 | +37.5% | 86,665 | -18.9% | 0.12% | +175.0% |
| Q4 2019 | $5,666,000 | +36.1% | 106,858 | +1.4% | 0.04% | +37.5% |
| Q3 2019 | $4,164,000 | -7.7% | 105,392 | -4.0% | 0.03% | -3.0% |
| Q2 2019 | $4,512,000 | -22.2% | 109,832 | -11.8% | 0.03% | -19.5% |
| Q1 2019 | $5,797,000 | +24.7% | 124,486 | +16.6% | 0.04% | +13.9% |
| Q4 2018 | $4,649,000 | -0.2% | 106,742 | +31.1% | 0.04% | +16.1% |
| Q3 2018 | $4,659,000 | +44.6% | 81,407 | +22.5% | 0.03% | +47.6% |
| Q2 2018 | $3,223,000 | +35.9% | 66,432 | +9.5% | 0.02% | +10.5% |
| Q1 2018 | $2,372,000 | +11.5% | 60,670 | +21.0% | 0.02% | +26.7% |
| Q4 2017 | $2,127,000 | +49.9% | 50,125 | +31.8% | 0.02% | +50.0% |
| Q3 2017 | $1,419,000 | +34.0% | 38,027 | +9.1% | 0.01% | +42.9% |
| Q2 2017 | $1,059,000 | +23.1% | 34,853 | +7.3% | 0.01% | +16.7% |
| Q1 2017 | $860,000 | -7.1% | 32,473 | -10.5% | 0.01% | -14.3% |
| Q4 2016 | $926,000 | -46.6% | 36,274 | -24.3% | 0.01% | -50.0% |
| Q3 2016 | $1,735,000 | -2.4% | 47,930 | -8.3% | 0.01% | -12.5% |
| Q2 2016 | $1,777,000 | +61.4% | 52,287 | +25.3% | 0.02% | +45.5% |
| Q1 2016 | $1,101,000 | -48.5% | 41,718 | -4.8% | 0.01% | -47.6% |
| Q4 2015 | $2,136,000 | -83.4% | 43,805 | -15.3% | 0.02% | +50.0% |
| Q3 2015 | $12,885,000 | +1151.0% | 51,747 | +58.9% | 0.01% | +55.6% |
| Q2 2015 | $1,030,000 | +68.3% | 32,559 | +102.6% | 0.01% | +80.0% |
| Q1 2015 | $612,000 | – | 16,073 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |